Category: Abbott LaboratoriesSyndicate content

Guidant didn't breach deal with J&J, says lawyer | Medtech legal news for the week of December 22, 2014

December 22, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Lawyer says Guidant didn't breach deal with J&J; Ex-Abbott stent liaison alleges retaliation for compliance complaint; Trial date set for Boston Scientific executive's accused killer; Analogic expects fines in BK Medical's Danish bribery beef; SEC dings Bruker in $2.4m China bribery case

Report: Lawyer says Guidant didn't breach deal with J&J

December 16, 2014 by Brad Perriello

YYmeta

Ex-Abbott stent liaison alleges retaliation for compliance complaint

December 17, 2014 by Brad Perriello

A former Abbott Vascular medical liaison alleges that the company fired her after she flagged Abbott for off-label promotion of its Xience stent and pre-approval marketing of its bioresorbable vascular scaffold.

Ex-Abbott stent liaison alleges retaliation for compliance complaint

Merger & acquisition activity surges this year | The week in medtech M&A

December 17, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtech M&A explodes in 2014; Synergetics pays $14m for Sterimedix; Report: Lawyer says Guidant didn't breach deal with J&J

Medtech M&A explodes in 2014

December 15, 2014 by Brad Perriello

Medtech M&A explodes in 2014

Report: Lawyer says Guidant didn't breach deal with J&J

December 16, 2014 by Brad Perriello

Guidant was within its rights to give due diligence materials to Abbott, even though it had an acquisition deal going with Johnson & Johnson, a former Guidant lawyer reportedly testifies.

YYmeta

Abbott Vascular lays off 100 in California

November 13, 2014 by Brad Perriello

Abbott Vascular reportedly lays off 100 workers at a plant in Temecula, Calif.

Abbott Vascular lays off 100 in California

Abbott Vascular (NYSE:ABT) is laying off about 100 workers at a California plant it acquired when it bought a portion of Guidant Corp. in 2006.

Plan for Medtronic-Covidien management structure unveiled | The week in medtech M&A

November 5, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic unveils post-merger management structure; Abbott buys into electrophysiology with $250m Topera acquisition; Zimmer reveals post-Biomet merger plans; Medtronic, Covidien merger expected to close in 2015; Covidien deals Stellarex balloon to Spectranetics for $30m

Medtronic unveils post-merger management structure

October 30, 2014 by Val Kennedy

Abbott buys into electrophysiology with $250m Topera acquisition

October 29, 2014 by Brad Perriello

Abbott pays $250 million plus milestones for Topera Medical and its cardiac arrhythmia mapping technology and inks a deal to acquire Advanced Cardiac Therapeutics and its ablation catheter.

Abbott buys into electrophysiology with $250m Topera acquisition

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp